Michael R Hayden - Net Worth and Insider Trading
Michael R Hayden Net Worth
The estimated net worth of Michael R Hayden is at least $18 Million dollars as of 2024-05-16. Michael R Hayden is the Director of Xenon Pharmaceuticals Inc and owns about 267,421 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $11 Million. Michael R Hayden is the Director of AbCellera Biologics Inc and owns about 1,441,642 shares of AbCellera Biologics Inc (ABCL) stock worth over $5 Million. Michael R Hayden is also the Director of 89bio Inc and owns about 246,420 shares of 89bio Inc (ETNB) stock worth over $2 Million. Details can be seen in Michael R Hayden's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael R Hayden has not made any transactions after 2023-09-22 and currently still holds the listed stock(s).
Transaction Summary of Michael R Hayden
Michael R Hayden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael R Hayden owns 5 companies in total, including Ionis Pharmaceuticals Inc (IONS) , 89bio Inc (ETNB) , and Xenon Pharmaceuticals Inc (XENE) among others .
Click here to see the complete history of Michael R Hayden’s form 4 insider trades.
Insider Ownership Summary of Michael R Hayden
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IONS | Ionis Pharmaceuticals Inc | 2018-09-20 | director |
| ETNB | 89bio Inc | 2023-03-28 | director |
| XENE | Xenon Pharmaceuticals Inc | 2019-03-11 | director |
 | | 2021-01-01 | director |
| | 2023-09-22 | director |
Michael R Hayden Latest Holdings Summary
Michael R Hayden currently owns a total of 3 stocks. Among these stocks, Michael R Hayden owns 267,421 shares of Xenon Pharmaceuticals Inc (XENE) as of August 14, 2017, with a value of $11 Million and a weighting of 58.73%. Michael R Hayden owns 1,441,642 shares of AbCellera Biologics Inc (ABCL) as of September 22, 2023, with a value of $5 Million and a weighting of 28.96%. Michael R Hayden also owns 246,420 shares of 89bio Inc (ETNB) as of March 28, 2023, with a value of $2 Million and a weighting of 12.31%.
Latest Holdings of Michael R Hayden
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2017-08-14 | 267,421 | 40.45 | 10,817,179 |
| ABCL | AbCellera Biologics Inc | 2023-09-22 | 1,441,642 | 3.70 | 5,334,075 |
| ETNB | 89bio Inc | 2023-03-28 | 246,420 | 9.20 | 2,267,064 |
Holding Weightings of Michael R Hayden
Michael R Hayden Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael R Hayden has made a total of 0 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years. The most-recent trade in Xenon Pharmaceuticals Inc is the acquisition of 15,000 shares on August 14, 2017, which cost Michael R Hayden around $41,250.
According to the SEC Form 4 filings, Michael R Hayden has made a total of 4 transactions in AbCellera Biologics Inc (ABCL) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in AbCellera Biologics Inc is the acquisition of 20,000 shares on September 22, 2023, which cost Michael R Hayden around $98,200.
According to the SEC Form 4 filings, Michael R Hayden has made a total of 2 transactions in 89bio Inc (ETNB) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in 89bio Inc is the acquisition of 87,788 shares on March 28, 2023, which cost Michael R Hayden around $1 Million.
Insider Trading History of Michael R Hayden
- 1
Michael R Hayden Trading Performance
GuruFocus tracks the stock performance after each of Michael R Hayden's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael R Hayden is 0.22%. GuruFocus also compares Michael R Hayden's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael R Hayden within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael R Hayden's insider trading performs compared to the benchmark.
Performance of Michael R Hayden
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.19 | | | | | |
| Relative Return to S&P 500(%) | 4.05 | | | | | |
Michael R Hayden Ownership Network
Michael R Hayden Owned Company Details
What does Ionis Pharmaceuticals Inc do?
Who are the key executives at Ionis Pharmaceuticals Inc?
Michael R Hayden is the director of Ionis Pharmaceuticals Inc. Other key executives at Ionis Pharmaceuticals Inc include EVP & Corp and Development Ops Brian Birchler , Chief Business Officer Joseph Baroldi , and director & Senior Vice President Brett P Monia .
Ionis Pharmaceuticals Inc (IONS) Insider Trades Summary
Over the past 18 months, Michael R Hayden made no insider transaction in Ionis Pharmaceuticals Inc (IONS). Other recent insider transactions involving Ionis Pharmaceuticals Inc (IONS) include a net sale of 183,300 shares made by Brett P Monia , a net sale of 57,263 shares made by Patrick R. O'neil , and a net sale of 67,074 shares made by C Frank Bennett .
In summary, during the past 3 months, insiders sold 10,911 shares of Ionis Pharmaceuticals Inc (IONS) in total and bought 0 shares, with a net sale of 10,911 shares. During the past 18 months, 645,101 shares of Ionis Pharmaceuticals Inc (IONS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 645,101 shares.
Ionis Pharmaceuticals Inc (IONS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ionis Pharmaceuticals Inc Insider Transactions
Michael R Hayden Mailing Address
Above is the net worth, insider trading, and ownership report for Michael R Hayden. You might contact Michael R Hayden via mailing address: C/o Aspreva Pharmaceuticals Corporation, 1203-4464 Markham Street, Victoria A1 V8z 7x8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
